Get started Log in

CVAC — CureVac NV Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
$1.05bn
Enterprise Value
$601.38m
Revenue
€535.18m

Brief: CureVac intends to offer $200 million of its common shares in an underwritten public offering
06/02/2023 22:18
CureVac up on promising data from flu and COVID-19 mRNA based vaccine
30/01/2023 15:58
Brief: Curevac: Positive Data In Older Adults From Covid-19, Flu MRNA Vaccine Development Programs
30/01/2023 12:03
BioNTech seeks to have CureVac patent nullified in German court
11/01/2023 17:16
Brief: Curevac Appoints Alexander Zehnder As CEO From April 1, 2023
09/01/2023 12:02
CureVac says COVID vaccine produced immune response in early-stage trial
06/01/2023 13:49
CureVac rises on positive data from joint COVID and flu mRNA vaccine programs
06/01/2023 13:27
Novavax shares lead declines among COVID vaccine makers
30/12/2022 19:43
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
05/12/2022 23:02
Researchers test mRNA technology for universal flu vaccine
24/11/2022 19:00
Brief: Curevac Q3 Pre-Tax Loss Of EUR 47.7 Million
16/11/2022 12:34
Pfizer, BioNTech seek to revoke CureVac's patent infringement claims (updated)
02/09/2022 15:05
Pfizer. BioNTech seek to revoke CureVac's patent infringement claims
02/09/2022 14:32
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine (updated)
26/08/2022 13:31
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
26/08/2022 13:00
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Coupa Software, Docusign
22/08/2022 18:42
Brief: Curevac Starts Phase 1 Clinical Study Of Modified, Omicron-Targeting Covid-19 Vaccine Candidate
18/08/2022 12:16
German stocks - Factors to watch on August 15
15/08/2022 05:48
BioNTech, Pfizer ask U.S. court for clearance over patent dispute with CureVac (updated)
26/07/2022 14:13
BioNTech, Pfizer ask U.S. court for clearance over patent dispute with CureVac
26/07/2022 13:15